The FDA has granted an orphan drug designation to gavocabtagene autoleucel as a
- This topic has 0 replies, 1 voice, and was last updated 2 years, 7 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
The FDA has granted an orphan drug designation to gavocabtagene autoleucel as a potential treatment for patients with cholangiocarcinoma.
https://clinicaltrials.gov/ct2/show/NCT03907852
Gavin
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.